Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial
| Image |  |
|---|---|
| Description | scientific article published on 14 November 2015 |
| Author/s |
author: Elisabeth Steinhagen-Thiessen Maurizio Averna Helen M. Colhoun |
| Publication date | November 14, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |